+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Gallamine Triethiodide Market by Indication (Anesthesia Adjunct, Neuromuscular Disorders), Dosage Form (Dosage Adjustment, Initial Dose, Maintenance Dose), Application, End-User - Forecast 2024-2030- Product Image
Global Gallamine Triethiodide Market by Indication (Anesthesia Adjunct, Neuromuscular Disorders), Dosage Form (Dosage Adjustment, Initial Dose, Maintenance Dose), Application, End-User - Forecast 2024-2030- Product Image
Sale

Global Gallamine Triethiodide Market by Indication (Anesthesia Adjunct, Neuromuscular Disorders), Dosage Form (Dosage Adjustment, Initial Dose, Maintenance Dose), Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967490
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gallamine Triethiodide Market size was estimated at USD 184.71 million in 2023, USD 192.74 million in 2024, and is expected to grow at a CAGR of 4.47% to reach USD 250.88 million by 2030.

Gallamine triethiodide is a synthetic, non-depolarizing, competitive, and reversible muscle relaxant primarily used in anesthesia to induce muscle relaxation, particularly in neuromuscular blocking. It works by blocking the action of acetylcholine at the neuromuscular junction, inhibiting the transmittance of nerve impulses in skeletal muscles. The increasing volume of surgical interventions requiring general anesthesia drives the need for muscle relaxants, including gallamine triethiodide. The growing geriatric population, more prone to surgeries and chronic diseases, further propels utilization and the need for effective neuromuscular-blocking agents.

Moreover, the global investment in expanding and modernizing healthcare infrastructure increases the availability of surgical and anesthesia services. However, the complex synthesis process of gallamine triethiodide can lead to increased production, which can hamper the usage of the relaxant. Additionally, ensuring consistent quality and efficacy across batches presents a significant challenge in its production, and the possibility of performance issues or failures of the relaxant can raise concerns about its safety and reliability. However, investments in R&D could pave the way for formulation improvements and new applications, enhancing its market position. Developing combination therapies with gallamine triethiodide may offer better patient outcomes, and leveraging technological advancements in drug delivery systems could improve the efficacy and safety profiles of gallamine triethiodide, driving its demand.

Regional Insights

In the Americas, the United States and Canada represent key nations for gallamine triethiodide, driven by advanced healthcare infrastructure and a high rate of surgeries requiring general anesthesia. The U.S. has seen considerable investment in R&D, leading to the emergence of innovative medical practices involving gallamine triethiodide. Customer purchasing behavior indicates a preference for products with minimal side effects and a push towards alternative anesthetic agents perceived as safer. In the European Union (EU) countries, stringent regulatory standards and a focus on healthcare innovation shape the market for gallamine triethiodide.

A well-established medical system and an aging population have established a need for surgical interventions. The MEA nations are experiencing growth due to improvements in healthcare infrastructure and increasing accessibility to medical care. Investments and initiatives in these regions tend to focus on expanding healthcare accessibility, which could increase the demand for anesthetic drugs, including gallamine triethiodide. The APAC region, especially China, Japan, and India, has seen significant growth in the demand for gallamine triethiodide driven by expanding healthcare facilities and increasing pharmaceutical manufacturing. Research and development activities are robust in this region, particularly in China and Japan, focusing on novel drug delivery systems incorporating gallamine triethiodide. Patents filed in these countries focus on improving the efficacy and reducing the side effects of anesthesia drugs. Government initiatives in India to boost the pharmaceutical sector have led to increased investment, making the region a lucrative market for gallamine triethiodide.

Market Trends by Segment

  • Indication: Expanding usage of gallamine triethiodide as an anesthesia adjuvant to facilitate surgical procedures by ensuring muscle relaxation
  • Application: Need for gallamine triethiodide in the healthcare sector to cater to the rising incidences of surgical interventions

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

FDA Approves Lupin's Generic Muscle Relaxant, Enhancing Healthcare Options in the U.S.

The United States Food and Drug Administration (USFDA) has recently approved a generic version of Gallamine Triethiodide, a muscle relaxant drug, developed by Lupin Pharmaceuticals. This authorization paves the way for an affordable alternative to the existing treatment options, providing healthcare practitioners and patients across the United States with an enhanced choice for muscle relaxation therapies.

Key Company Profiles

The report delves into recent significant developments in the Gallamine Triethiodide Market, highlighting leading vendors and their innovative profiles. These include Adooq Bioscience LLC., Angle Bio Pharma, BioCrick Co., Ltd., Biosynth Ltd, BOC Sciences, Chemcopia Ingredients Pvt. Ltd., ChemScene, Glentham Life Sciences Limited, LGC Limited, Merck KGaA, National Analytical Corporation, Pharmaffiliates, Procurenet Limited, Santa Cruz Biotechnology, Inc., Selleck Chemicals LLC, SimSon Pharma Limited, and Thermo Fisher Scientific Inc.

This research report offers invaluable insights into various crucial aspects of the Gallamine Triethiodide Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of surgical interventions that need general anesthesia
5.1.1.2. Government investments in improving healthcare infrastructure and providing access to surgeries
5.1.2. Restraints
5.1.2.1. Issues associated with production and quality control
5.1.3. Opportunities
5.1.3.1. Ongoing advancements to improve the safety and performance of gallamine triethiodide
5.1.3.2. Leveraging technological advancements and innovations in drug delivery systems
5.1.4. Challenges
5.1.4.1. Possibility of failure and performance issues
5.2. Market Segmentation Analysis
5.2.1. Indication: Expanding usage of gallamine triethiodide as an anesthesia adjuvant to facilitate surgical procedures by ensuring muscle relaxation
5.2.2. Application: Need for gallamine triethiodide in the healthcare sector to cater to the rising incidences of surgical interventions
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Gallamine Triethiodide Market, by Indication
6.1. Introduction
6.2. Anesthesia Adjunct
6.3. Neuromuscular Disorders
7. Gallamine Triethiodide Market, by Dosage Form
7.1. Introduction
7.2. Dosage Adjustment
7.3. Initial Dose
7.4. Maintenance Dose
8. Gallamine Triethiodide Market, by Application
8.1. Introduction
8.2. Healthcare
8.3. Research
9. Gallamine Triethiodide Market, by End-User
9.1. Introduction
9.2. Clinics
9.3. Hospitals
9.4. Research Institutions
10. Americas Gallamine Triethiodide Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Gallamine Triethiodide Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Gallamine Triethiodide Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. FDA Approves Lupin's Generic Muscle Relaxant, Enhancing Healthcare Options in the U.S.
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. GALLAMINE TRIETHIODIDE MARKET RESEARCH PROCESS
FIGURE 2. GALLAMINE TRIETHIODIDE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GALLAMINE TRIETHIODIDE MARKET DYNAMICS
FIGURE 7. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
FIGURE 10. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GALLAMINE TRIETHIODIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS GALLAMINE TRIETHIODIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GALLAMINE TRIETHIODIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES GALLAMINE TRIETHIODIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GALLAMINE TRIETHIODIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GALLAMINE TRIETHIODIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. GALLAMINE TRIETHIODIDE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. GALLAMINE TRIETHIODIDE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GALLAMINE TRIETHIODIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY ANESTHESIA ADJUNCT, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY ANESTHESIA ADJUNCT, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY NEUROMUSCULAR DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY NEUROMUSCULAR DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE ADJUSTMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE ADJUSTMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY INITIAL DOSE, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY INITIAL DOSE, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY MAINTENANCE DOSE, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY MAINTENANCE DOSE, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY HEALTHCARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY RESEARCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL GALLAMINE TRIETHIODIDE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS GALLAMINE TRIETHIODIDE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS GALLAMINE TRIETHIODIDE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. CANADA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 62. CANADA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 63. CANADA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 64. CANADA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 65. CANADA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. CANADA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. CANADA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 68. CANADA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 69. MEXICO GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 70. MEXICO GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 71. MEXICO GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 72. MEXICO GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 73. MEXICO GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. MEXICO GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. MEXICO GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 76. MEXICO GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES GALLAMINE TRIETHIODIDE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES GALLAMINE TRIETHIODIDE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC GALLAMINE TRIETHIODIDE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC GALLAMINE TRIETHIODIDE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 97. AUSTRALIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 98. AUSTRALIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 105. CHINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 106. CHINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 107. CHINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 108. CHINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 109. CHINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 110. CHINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 111. CHINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. CHINA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. INDIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 114. INDIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 115. INDIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 116. INDIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 117. INDIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. INDIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. INDIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 120. INDIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 121. INDONESIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 122. INDONESIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 123. INDONESIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 124. INDONESIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 125. INDONESIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. INDONESIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 129. JAPAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 130. JAPAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 131. JAPAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 132. JAPAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 133. JAPAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. JAPAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. JAPAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. JAPAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. MALAYSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 138. MALAYSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 139. MALAYSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 140. MALAYSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 141. MALAYSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. MALAYSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 145. PHILIPPINES GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 146. PHILIPPINES GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 147. PHILIPPINES GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 148. PHILIPPINES GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 149. PHILIPPINES GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. PHILIPPINES GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. SINGAPORE GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 154. SINGAPORE GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 155. SINGAPORE GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 156. SINGAPORE GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 157. SINGAPORE GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. SINGAPORE GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. SOUTH KOREA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 162. SOUTH KOREA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 163. SOUTH KOREA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 164. SOUTH KOREA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 165. SOUTH KOREA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 166. SOUTH KOREA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 169. TAIWAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 170. TAIWAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 171. TAIWAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 172. TAIWAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 173. TAIWAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. TAIWAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 177. THAILAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 178. THAILAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 179. THAILAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 180. THAILAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 181. THAILAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. THAILAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. THAILAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 184. THAILAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 185. VIETNAM GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 186. VIETNAM GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 187. VIETNAM GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 188. VIETNAM GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 189. VIETNAM GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 190. VIETNAM GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 203. DENMARK GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 204. DENMARK GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 205. DENMARK GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 206. DENMARK GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 207. DENMARK GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. DENMARK GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. DENMARK GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. DENMARK GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. EGYPT GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 212. EGYPT GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 213. EGYPT GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 214. EGYPT GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 215. EGYPT GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. EGYPT GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. EGYPT GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 218. EGYPT GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 219. FINLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 220. FINLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 221. FINLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 222. FINLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 223. FINLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. FINLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. FINLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. FINLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. FRANCE GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 228. FRANCE GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 229. FRANCE GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 230. FRANCE GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 231. FRANCE GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 232. FRANCE GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 233. FRANCE GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 234. FRANCE GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 235. GERMANY GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 236. GERMANY GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 237. GERMANY GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 238. GERMANY GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 239. GERMANY GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. GERMANY GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. GERMANY GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 242. GERMANY GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 243. ISRAEL GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 244. ISRAEL GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 245. ISRAEL GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 246. ISRAEL GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 247. ISRAEL GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. ISRAEL GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. ITALY GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 252. ITALY GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 253. ITALY GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 254. ITALY GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 255. ITALY GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 256. ITALY GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 257. ITALY GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 258. ITALY GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 259. NETHERLANDS GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 260. NETHERLANDS GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 261. NETHERLANDS GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 262. NETHERLANDS GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 263. NETHERLANDS GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. NETHERLANDS GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 267. NIGERIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 268. NIGERIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 269. NIGERIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 270. NIGERIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 271. NIGERIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. NIGERIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. NORWAY GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 276. NORWAY GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 277. NORWAY GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 278. NORWAY GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 279. NORWAY GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. NORWAY GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. NORWAY GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. NORWAY GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. POLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 284. POLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 285. POLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 286. POLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 287. POLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. POLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. POLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 290. POLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 291. QATAR GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 292. QATAR GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 293. QATAR GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 294. QATAR GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 295. QATAR GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 296. QATAR GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 297. QATAR GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 298. QATAR GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 299. RUSSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 300. RUSSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 301. RUSSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 302. RUSSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 303. RUSSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 304. RUSSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 308. SAUDI ARABIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 310. SAUDI ARABIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 312. SAUDI ARABIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 316. SOUTH AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 318. SOUTH AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 320. SOUTH AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 322. SOUTH AFRICA GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 323. SPAIN GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 324. SPAIN GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 325. SPAIN GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 326. SPAIN GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 327. SPAIN GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 328. SPAIN GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 329. SPAIN GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 330. SPAIN GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 331. SWEDEN GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 332. SWEDEN GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 333. SWEDEN GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 334. SWEDEN GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 335. SWEDEN GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 336. SWEDEN GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 337. SWEDEN GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 338. SWEDEN GALLAMINE TRIETHIODIDE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 339. SWITZERLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 340. SWITZERLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 341. SWITZERLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2018-2023 (USD MILLION)
TABLE 342. SWITZERLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY DOSAGE FORM, 2024-2030 (USD MILLION)
TABLE 343. SWITZERLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 344. SWITZERLAND GALLAMINE TRIETHIODIDE MARKET SIZE, BY APPLICATION, 2

Companies Mentioned

  • Adooq Bioscience LLC.
  • Angle Bio Pharma
  • BioCrick Co., Ltd.
  • Biosynth Ltd
  • BOC Sciences
  • Chemcopia Ingredients Pvt. Ltd.
  • ChemScene
  • Glentham Life Sciences Limited
  • LGC Limited
  • Merck KGaA
  • National Analytical Corporation
  • Pharmaffiliates
  • Procurenet Limited
  • Santa Cruz Biotechnology, Inc.
  • Selleck Chemicals LLC
  • SimSon Pharma Limited
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 192.74 Million
Forecasted Market Value ( USD ) by 2030 $ 250.88 Million
Compound Annual Growth Rate4.4%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Gallamine triethiodide (CAS 65-29-2) Global Market Research Report 2024 - Product Image

Gallamine triethiodide (CAS 65-29-2) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Global Ankylosing Spondylitis Market by Drug (Cimzia, Cosentyx, Enbrel), Type of Molecule (Biologics, Small Molecules), Mechanism Of Action, Route Of Administration, Dosage Forms, End User - Forecast 2024-2030 - Product Image

Global Ankylosing Spondylitis Market by Drug (Cimzia, Cosentyx, Enbrel), Type of Molecule (Biologics, Small Molecules), Mechanism Of Action, Route Of Administration, Dosage Forms, End User - Forecast 2024-2030

  • Report
  • 193 Pages
  • Global
From
Global Raloxifene Hydrochloride Market by Dosage Form (Capsule, Tablets), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Pharmacy) - Forecast 2024-2030 - Product Image

Global Raloxifene Hydrochloride Market by Dosage Form (Capsule, Tablets), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Pharmacy) - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
AREXVY Market Size, Forecast, and Market Insight - 2032 - Product Image

AREXVY Market Size, Forecast, and Market Insight - 2032

  • Report
  • 30 Pages
  • Global
From
US HUMIRA Market Size, Forecast, and Market Insight - 2032 - Product Image

US HUMIRA Market Size, Forecast, and Market Insight - 2032

  • Report
  • 30 Pages
  • United States

About the Gallamine Triethiodide Market

Gallamine Triethiodide is a drug used to treat musculoskeletal disorders. It is a muscle relaxant that works by blocking the action of the neurotransmitter acetylcholine, which is responsible for muscle contraction. It is used to treat conditions such as muscle spasms, muscle cramps, and muscle stiffness. It is also used to treat conditions such as tetanus, spasticity, and multiple sclerosis. Gallamine Triethiodide is available in both oral and injectable forms. Gallamine Triethiodide is a widely used drug in the treatment of musculoskeletal disorders. It is generally well tolerated and has few side effects. It is also relatively inexpensive compared to other muscle relaxants. However, it is not recommended for use in pregnant women or those with certain medical conditions. The Gallamine Triethiodide market is highly competitive, with many companies offering the drug. Some of the major players in the market include Pfizer, Merck, Novartis, and Sanofi. Other companies include Mylan, Teva, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.